381 related articles for article (PubMed ID: 25965397)
1. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
March MI; Geahchan C; Wenger J; Raghuraman N; Berg A; Haddow H; Mckeon BA; Narcisse R; David JL; Scott J; Thadhani R; Karumanchi SA; Rana S
PLoS One; 2015; 10(5):e0126815. PubMed ID: 25965397
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
[TBL] [Abstract][Full Text] [Related]
3. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
[TBL] [Abstract][Full Text] [Related]
4. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
[TBL] [Abstract][Full Text] [Related]
5. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
[TBL] [Abstract][Full Text] [Related]
6. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
[TBL] [Abstract][Full Text] [Related]
7. PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies.
Rana S; Hacker M; Merport A; Salahuddin S; Verlohren S; Perschel F; Karumanchi SA
Pregnancy Hypertens; 2012 Jul; 2(3):273-4. PubMed ID: 26105382
[TBL] [Abstract][Full Text] [Related]
8. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.
Rana S; Powe CE; Salahuddin S; Verlohren S; Perschel FH; Levine RJ; Lim KH; Wenger JB; Thadhani R; Karumanchi SA
Circulation; 2012 Feb; 125(7):911-9. PubMed ID: 22261192
[TBL] [Abstract][Full Text] [Related]
11. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
[TBL] [Abstract][Full Text] [Related]
12. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia.
Baltajian K; Hecht JL; Wenger JB; Salahuddin S; Verlohren S; Perschel FH; Zsengeller ZK; Thadhani R; Karumanchi SA; Rana S
Hypertens Pregnancy; 2014 Nov; 33(4):427-39. PubMed ID: 25062083
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
14. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
[TBL] [Abstract][Full Text] [Related]
15. Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies.
Staff AC; Harsem NK; Braekke K; Hyer M; Hoover RN; Troisi R
Eur J Obstet Gynecol Reprod Biol; 2009 Mar; 143(1):29-33. PubMed ID: 19135290
[TBL] [Abstract][Full Text] [Related]
16. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.
Pinheiro CC; Rayol P; Gozzani L; Reis LM; Zampieri G; Dias CB; Woronik V
Prenat Diagn; 2014 Nov; 34(11):1084-92. PubMed ID: 24916790
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
[TBL] [Abstract][Full Text] [Related]
18. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
[TBL] [Abstract][Full Text] [Related]
19. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.
Cohen AL; Wenger JB; James-Todd T; Lamparello BM; Halprin E; Serdy S; Fan S; Horowitz GL; Lim KH; Rana S; Takoudes TC; Wyckoff JA; Thadhani R; Karumanchi SA; Brown FM
Hypertens Pregnancy; 2014 Feb; 33(1):81-92. PubMed ID: 24354578
[TBL] [Abstract][Full Text] [Related]
20. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.
Rana S; Hacker MR; Modest AM; Salahuddin S; Lim KH; Verlohren S; Perschel FH; Karumanchi SA
Hypertension; 2012 Aug; 60(2):451-8. PubMed ID: 22753210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
